デフォルト表紙
市場調査レポート
商品コード
1700984

ドネペジルの世界市場:市場規模、メーカー、サプライチェーン、販売チャネル、顧客 2025-2031年までの予測

Global Donepezil Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031


出版日
発行
QYResearch
ページ情報
英文 149 Pages
納期
2~3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
ドネペジルの世界市場:市場規模、メーカー、サプライチェーン、販売チャネル、顧客 2025-2031年までの予測
出版日: 2025年04月11日
発行: QYResearch
ページ情報: 英文 149 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ドネペジル (Donepezil) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • ドネペジルの製品概要
  • 市場:タイプ別
    • 世界のドネペジルの市場規模成長率:タイプ別 (2020 VS 2024 VS 2031)
    • 5mg
    • 10mg
    • 23mg
  • 市場:用途別
    • 世界のドネペジルの市場規模成長率:用途別 (2020 VS 2024 VS 2031)
    • Hospitals
    • Clinics
    • Drugstore
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のドネペジル 市場規模 推定および予測
    • 世界のドネペジル 収益 2020-2031
    • 世界のドネペジル 売上 2020-2031
  • ドネペジル 市場規模:地域別: 2024 VS 2031
  • ドネペジル 販売:地域別 (2020-2031)
    • 世界のドネペジル 販売:地域別: 2020-2025
    • 世界のドネペジルの販売予測:地域別 (2026-2031)
    • 世界のドネペジルの販売市場シェア 地域別 (2020-2031)
  • ドネペジルの市場 推定および予測:地域別 (2026-2031)
    • 世界のドネペジル 収益:地域別: 2020-2025
    • 世界のドネペジルの収益予測:地域別 (2026-2031)
    • 世界のドネペジルの収益市場シェア 地域別 (2020-2031)

第3章 市場セグメント

  • 内訳データ:タイプ別
    • 世界のドネペジル 販売:タイプ別 (2020-2031)
    • 世界のドネペジル 収益:タイプ別 (2020-2031)
    • ドネペジル 平均 販売価格:タイプ別 (2020-2031)
  • 内訳データ:用途別
    • 世界のドネペジル 販売:用途別 (2020-2031)
    • 世界のドネペジル 収益:用途別 (2020-2031)
    • ドネペジル 平均 販売価格 (ASP) 用途別 (2020-2031)
  • タイプ別および用途別 交差分析
    • 5mg of Donepezil Revenue Market Share by Application
    • 10mg of Donepezil Revenue Market Share by Application
    • 23mg of Donepezil Revenue Market Share by Application

第4章 世界のドネペジル :企業別

  • 世界のドネペジルの上位企業:販売別 (2020-2025)
    • 世界のドネペジルの販売:企業別 (2020-2025)
    • 世界のドネペジルの販売市場シェア:企業別 (2020-2025)
  • 世界のドネペジルの上位企業:収益別 (2020-2025)
    • 世界のドネペジル 収益 メーカー別 (2020-2025)
    • 世界のドネペジル 収益 シェア メーカー別 (2020-2025)
  • 世界のドネペジル 価格 メーカー別 (2020-2025)
  • 競合状況
    • ドネペジルの主要メーカー: 売上高ランキング
    • 世界のドネペジル 市場集中度 (CR5 and HHI) & (2020-2025)
    • 世界のドネペジルの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界のドネペジルの製造拠点分布, 製品タイプ
    • Donepezil Manufacturers Manufacturing Base Distribution, Headquarters
    • Date of International Manufacturers Enter into Donepezil Market
    • Manufacturers Donepezil Product Type and Application
    • 5mg Market Sales of Donepezil by Manufacturer
    • 10mg Market Sales of Donepezil by Manufacturer
    • 23mg Market Sales of Donepezil by Manufacturer
  • 企業のM&A, 拡張計画

第5章 企業プロファイル

  • Eisai
  • Pfizer
  • Teva
  • Sandoz
  • Apotex
  • Dr Reddy's Laboratories
  • Sun Pharmaceutical
  • Hansoh Pharma
  • Cipla
  • ARK PHA.LTD
  • Jishengtang Pharma
  • Luoxin

第6章 北米

  • 北米のドネペジルの市場規模:対前年成長率 2020-2031
  • 北米のドネペジルの市場概要と数値:国別
    • 北米のドネペジルの販売:国別 (2020-2031)
    • 北米のドネペジルの収益:国別 (2020-2031)
  • 北米のドネペジル 販売:タイプ別 (2020-2025)
  • 北米のドネペジル 販売:用途別 (2020-2025)

第7章 アジア太平洋地域

  • アジア太平洋地域 ドネペジルの市場規模:対前年成長率 2020-2031
  • アジア太平洋地域 ドネペジルの市場概要と数値:地域別
    • アジア太平洋地域 ドネペジル 販売:地域別 (2020-2031)
    • アジア太平洋地域 ドネペジル 収益:地域別 (2020-2031)
  • アジア太平洋地域 ドネペジル 販売:タイプ別 (2020-2025)
  • アジア太平洋地域 ドネペジル 販売:用途別 (2020-2025)

第8章 欧州

  • 欧州のドネペジルの市場規模:対前年成長率 2020-2031
  • 欧州のドネペジルの市場概要と数値:国別
    • 欧州のドネペジルの販売:国別 (2020-2031)
    • 欧州のドネペジルの収益:国別 (2020-2031)
  • 欧州のドネペジル 販売:タイプ別 (2020-2025)
  • 欧州のドネペジル 販売:用途別 (2020-2025)

第9章 ラテンアメリカ

  • ラテンアメリカのドネペジルの市場規模:対前年成長率 2020-2031
  • ラテンアメリカのドネペジルの市場概要と数値:国別
    • ラテンアメリカのドネペジルの販売:国別 (2020-2031)
    • ラテンアメリカのドネペジルの収益:国別 (2020-2031)
  • ラテンアメリカのドネペジル 販売:タイプ別 (2020-2025)
  • ラテンアメリカのドネペジル 販売:用途別 (2020-2025)

第10章 中東・アフリカ

  • ラテンアメリカのドネペジルの市場規模:対前年成長率 2020-2031
  • 中東・アフリカのドネペジルの市場概要と数値:国別
    • 中東・アフリカのドネペジルの販売:国別 (2020-2031)
    • 中東・アフリカのドネペジルの収益:国別 (2020-2031)
  • 中東・アフリカのドネペジル 販売:タイプ別 (2020-2025)
  • 中東・アフリカのドネペジル 販売:用途別 (2020-2025)

第11章 サプライチェーンと販売チャネル分析

  • ドネペジル サプライチェーン分析
  • ドネペジル 主要原材料 and 上流サプライヤー
  • ドネペジル 顧客分析
  • ドネペジル 販売チャネル and 販売モデル分析
    • ドネペジル 流通チャネル分析: 間接販売 VS 直接販売
    • ドネペジル 流通チャネル分析: オンライン販売 VS オフライン販売
    • ドネペジル 卸業者

第12章 ドネペジル 市場動向

  • ドネペジル 業界動向
  • ドネペジル 市場の促進要因
  • ドネペジル 市場の課題
  • ドネペジル 市場の抑制要因

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

Table 1. Global Donepezil Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Donepezil Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Donepezil Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Donepezil Sales by Region (2020-2025) & (M Units)

Table 5. Global Donepezil Sales Forecast by Region (2026-2031) & (M Units)

Table 6. Global Donepezil Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Donepezil Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Donepezil Sales Volume by Type (2020-2025) & (M Units)

Table 9. Global Donepezil Sales Volume by Type (2026-2031) & (M Units)

Table 10. Global Donepezil Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Donepezil Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Donepezil Sales Volume by Application (2020-2025) & (M Units)

Table 13. Global Donepezil Sales Volume by Application (2026-2031) & (M Units)

Table 14. Global Donepezil Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Donepezil Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Donepezil Sales by Manufacturer (2020-2025) & (M Units)

Table 17. Global Donepezil Sales Share by Manufacturer (2020-2025)

Table 18. Donepezil Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Donepezil Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Donepezil Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Donepezil Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Donepezil Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Donepezil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Donepezil as of 2024)

Table 24. Donepezil Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Donepezil Market

Table 26. Manufacturers Donepezil Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Eisai Company Information

Table 29. Eisai Description and Business Overview

Table 30. Eisai Donepezil Product

Table 31. Eisai Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Eisai Sales Proportion of Donepezil by Product in 2024

Table 33. Eisai Sales Proportion of Donepezil by Application in 2024

Table 34. Eisai Sales Proportion of Donepezil by Geographic Area in 2024

Table 35. Eisai Recent Developments

Table 36. Pfizer Company Information

Table 37. Pfizer Description and Business Overview

Table 38. Pfizer Donepezil Product

Table 39. Pfizer Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Pfizer Sales Proportion of Donepezil by Product in 2024

Table 41. Pfizer Sales Proportion of Donepezil by Application in 2024

Table 42. Pfizer Sales Proportion of Donepezil by Geographic Area in 2024

Table 43. Pfizer Recent Developments

Table 44. Teva Company Information

Table 45. Teva Description and Business Overview

Table 46. Teva Donepezil Product

Table 47. Teva Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Teva Sales Proportion of Donepezil by Product in 2024

Table 49. Teva Sales Proportion of Donepezil by Application in 2024

Table 50. Teva Sales Proportion of Donepezil by Geographic Area in 2024

Table 51. Teva Recent Developments

Table 52. Sandoz Company Information

Table 53. Sandoz Description and Business Overview

Table 54. Sandoz Donepezil Product

Table 55. Sandoz Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Sandoz Sales Proportion of Donepezil by Product in 2024

Table 57. Sandoz Sales Proportion of Donepezil by Application in 2024

Table 58. Sandoz Sales Proportion of Donepezil by Geographic Area in 2024

Table 59. Sandoz Recent Developments

Table 60. Apotex Company Information

Table 61. Apotex Description and Business Overview

Table 62. Apotex Donepezil Product

Table 63. Apotex Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Apotex Sales Proportion of Donepezil by Product in 2024

Table 65. Apotex Sales Proportion of Donepezil by Application in 2024

Table 66. Apotex Sales Proportion of Donepezil by Geographic Area in 2024

Table 67. Apotex Recent Developments

Table 68. Dr Reddy's Laboratories Company Information

Table 69. Dr Reddy's Laboratories Description and Business Overview

Table 70. Dr Reddy's Laboratories Donepezil Product

Table 71. Dr Reddy's Laboratories Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Dr Reddy's Laboratories Sales Proportion of Donepezil by Product in 2024

Table 73. Dr Reddy's Laboratories Sales Proportion of Donepezil by Application in 2024

Table 74. Dr Reddy's Laboratories Sales Proportion of Donepezil by Geographic Area in 2024

Table 75. Dr Reddy's Laboratories Recent Developments

Table 76. Sun Pharmaceutical Company Information

Table 77. Sun Pharmaceutical Description and Business Overview

Table 78. Sun Pharmaceutical Donepezil Product

Table 79. Sun Pharmaceutical Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Sun Pharmaceutical Sales Proportion of Donepezil by Product in 2024

Table 81. Sun Pharmaceutical Sales Proportion of Donepezil by Application in 2024

Table 82. Sun Pharmaceutical Sales Proportion of Donepezil by Geographic Area in 2024

Table 83. Sun Pharmaceutical Recent Developments

Table 84. Hansoh Pharma Company Information

Table 85. Hansoh Pharma Description and Business Overview

Table 86. Hansoh Pharma Donepezil Product

Table 87. Hansoh Pharma Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Hansoh Pharma Sales Proportion of Donepezil by Product in 2024

Table 89. Hansoh Pharma Sales Proportion of Donepezil by Application in 2024

Table 90. Hansoh Pharma Sales Proportion of Donepezil by Geographic Area in 2024

Table 91. Hansoh Pharma Recent Developments

Table 92. Cipla Company Information

Table 93. Cipla Description and Business Overview

Table 94. Cipla Donepezil Product

Table 95. Cipla Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 96. Cipla Sales Proportion of Donepezil by Product in 2024

Table 97. Cipla Sales Proportion of Donepezil by Application in 2024

Table 98. Cipla Sales Proportion of Donepezil by Geographic Area in 2024

Table 99. Cipla Recent Developments

Table 100. ARK PHA.LTD Company Information

Table 101. ARK PHA.LTD Description and Business Overview

Table 102. ARK PHA.LTD Donepezil Product

Table 103. ARK PHA.LTD Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 104. ARK PHA.LTD Sales Proportion of Donepezil by Product in 2024

Table 105. ARK PHA.LTD Sales Proportion of Donepezil by Application in 2024

Table 106. ARK PHA.LTD Sales Proportion of Donepezil by Geographic Area in 2024

Table 107. ARK PHA.LTD Recent Developments

Table 108. Jishengtang Pharma Company Information

Table 109. Jishengtang Pharma Description and Business Overview

Table 110. Jishengtang Pharma Donepezil Product

Table 111. Jishengtang Pharma Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 112. Jishengtang Pharma Sales Proportion of Donepezil by Product in 2024

Table 113. Jishengtang Pharma Sales Proportion of Donepezil by Application in 2024

Table 114. Jishengtang Pharma Sales Proportion of Donepezil by Geographic Area in 2024

Table 115. Jishengtang Pharma Recent Developments

Table 116. Luoxin Company Information

Table 117. Luoxin Description and Business Overview

Table 118. Luoxin Donepezil Product

Table 119. Luoxin Donepezil Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 120. Luoxin Sales Proportion of Donepezil by Product in 2024

Table 121. Luoxin Sales Proportion of Donepezil by Application in 2024

Table 122. Luoxin Sales Proportion of Donepezil by Geographic Area in 2024

Table 123. Luoxin Recent Developments

Table 124. North America Donepezil Sales by Country (2020-2025) & (M Units)

Table 125. North America Donepezil Sales by Country (2026-2031) & (M Units)

Table 126. North America Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 127. North America Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 128. North America Donepezil Sales by Type (2020-2025) & (M Units)

Table 129. North America Donepezil Sales by Application (2020-2025) & (M Units)

Table 130. Asia-Pacific Donepezil Sales by Region (2020-2025) & (M Units)

Table 131. Asia-Pacific Donepezil Sales by Region (2026-2031) & (M Units)

Table 132. Asia-Pacific Donepezil Revenue by Region (2020-2025) & (US$ Million)

Table 133. Asia-Pacific Donepezil Revenue by Region (2026-2031) & (US$ Million)

Table 134. Asia-Pacific Donepezil Sales by Type (2020-2025) & (M Units)

Table 135. Asia-Pacific Donepezil Sales by Application (2020-2025) & (M Units)

Table 136. Europe Donepezil Sales by Country (2020-2025) & (M Units)

Table 137. Europe Donepezil Sales by Country (2026-2031) & (M Units)

Table 138. Europe Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 139. Europe Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 140. Europe Donepezil Sales by Type (2020-2025) & (M Units)

Table 141. Europe Donepezil Sales by Application (2020-2025) & (M Units)

Table 142. Latin America Donepezil Sales by Country (2020-2025) & (M Units)

Table 143. Latin America Donepezil Sales by Country (2026-2031) & (M Units)

Table 144. Latin America Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 145. Latin America Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 146. Latin America Donepezil Sales by Type (2020-2025) & (M Units)

Table 147. Latin America Donepezil Sales by Application (2020-2025) & (M Units)

Table 148. Middle East and Africa Donepezil Sales by Country (2020-2025) & (M Units)

Table 149. Middle East and Africa Donepezil Sales by Country (2026-2031) & (M Units)

Table 150. Middle East and Africa Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 151. Middle East and Africa Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 152. Middle East and Africa Donepezil Sales by Type (2020-2025) & (M Units)

Table 153. Middle East and Africa Donepezil Sales by Application (2020-2025) & (M Units)

Table 154. Donepezil Key Raw Materials, Industry Status and Trend

Table 155. Donepezil Key Raw Materials and Upstream Suppliers

Table 156. Donepezil Clients Status and Trend

Table 157. Donepezil Typical Clients

Table 158. Donepezil Distributors

Table 159. Donepezil Market Trends

Table 160. Donepezil Market Drivers

Table 161. Donepezil Market Challenges

Table 162. Donepezil Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Donepezil Product Picture

Figure 2. Global Donepezil Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Donepezil Sales Market Share by Type in 2024 & 2031

Figure 4. 5mg Product Picture

Figure 5. 10mg Product Picture

Figure 6. 23mg Product Picture

Figure 7. Global Donepezil Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Donepezil Sales Market Share by Application in 2024 & 2031

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Drugstore

Figure 12. Donepezil Report Years Considered

Figure 13. Global Donepezil Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Donepezil Market Size 2020-2031 (US$ Million)

Figure 15. Global Donepezil Sales 2020-2031 (M Units)

Figure 16. Global Donepezil Sales Market Share Forecast by Region (2020-2031)

Figure 17. Global Donepezil Revenue Market Share by Region (2020-2031)

Figure 18. Global Donepezil Sales Market Share Forecast by Type (2020-2031)

Figure 19. Global Donepezil Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Donepezil Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 21. Global Donepezil Sales Market Share Forecast by Application (2020-2031)

Figure 22. Global Donepezil Revenue Market Share Forecast by Application (2020-2031)

Figure 23. Donepezil Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 24. 5mg of Donepezil Revenue Market Share by Application, 2024 VS 2031

Figure 25. 10mg of Donepezil Revenue Market Share by Application, 2024 VS 2031

Figure 26. 23mg of Donepezil Revenue Market Share by Application, 2024 VS 2031

Figure 27. Global Donepezil Sales Share by Manufacturer in 2024

Figure 28. Donepezil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. 5mg Market Sales Proportion by Manufacturer in 2024

Figure 30. 10mg Market Sales Proportion by Manufacturer in 2024

Figure 31. 23mg Market Sales Proportion by Manufacturer in 2024

Figure 32. North America Donepezil Revenue 2020-2031 (US$ Million)

Figure 33. North America Donepezil Sales Market Share by Type (2020-2025)

Figure 34. North America Donepezil Sales Market Share by Application (2020-2025)

Figure 35. Asia-Pacific Donepezil Revenue 2020-2031 (US$ Million)

Figure 36. Asia-Pacific Donepezil Sales Market Share by Region (2020-2031)

Figure 37. Asia-Pacific Donepezil Revenue Market Share by Region (2020-2031)

Figure 38. Asia-Pacific Donepezil Sales Market Share by Type (2020-2025)

Figure 39. Asia-Pacific Donepezil Sales Market Share by Application (2020-2025)

Figure 40. Europe Donepezil Revenue Growth Rate 2020-2031 (US$ Million)

Figure 41. Europe Donepezil Sales Market Share by Country (2020-2031)

Figure 42. Europe Donepezil Revenue Market Share by Country (2020-2031)

Figure 43. Europe Donepezil Sales Market Share by Type (2020-2025)

Figure 44. Europe Donepezil Sales Market Share by Application (2020-2025)

Figure 45. Latin America Donepezil Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Latin America Donepezil Sales Market Share by Country (2020-2031)

Figure 47. Latin America Donepezil Revenue Market Share by Country (2020-2025)

Figure 48. Latin America Donepezil Sales Market Share by Type (2020-2025)

Figure 49. Latin America Donepezil Sales Market Share by Application (2020-2025)

Figure 50. Middle East and Africa Donepezil Revenue Growth Rate 2020-2031 (US$ Million)

Figure 51. Middle East and Africa Donepezil Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Donepezil Revenue Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Donepezil Sales Market Share by Type (2020-2025)

Figure 54. Middle East and Africa Donepezil Sales Market Share by Application (2020-2025)

Figure 55. Donepezil Supply Chain (Upstream and Downstream Market)

Figure 56. Global Production Market Share of Donepezil Raw Materials by Region in 2024

Figure 57. Donepezil Distribution Channels

Figure 58. Global Donepezil Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 59. Global Donepezil Percentage 2020-2031: Online Sales VS Offline Sales

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

目次

This research report focuses on the Donepezil Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Donepezil Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Donepezil Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
    • 1.2.2 5mg
    • 1.2.3 10mg
    • 1.2.4 23mg
  • 1.3 Market by Application
    • 1.3.1 Global Donepezil Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Drugstore
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Donepezil Market Size Estimates and Forecasts
    • 2.1.1 Global Donepezil Revenue 2020-2031
    • 2.1.2 Global Donepezil Sales 2020-2031
  • 2.2 Donepezil Market Size by Region: 2024 Versus 2031
  • 2.3 Donepezil Sales by Region (2020-2031)
    • 2.3.1 Global Donepezil Sales by Region: 2020-2025
    • 2.3.2 Global Donepezil Sales Forecast by Region (2026-2031)
    • 2.3.3 Global Donepezil Sales Market Share by Region (2020-2031)
  • 2.4 Donepezil Market Estimates and Projections by Region (2026-2031)
    • 2.4.1 Global Donepezil Revenue by Region: 2020-2025
    • 2.4.2 Global Donepezil Revenue Forecast by Region (2026-2031)
    • 2.4.3 Global Donepezil Revenue Market Share by Region (2020-2031)

3 Market Segments

  • 3.1 Breakdown Data by Type
    • 3.1.1 Global Donepezil Sales by Type (2020-2031)
      • 3.1.1.1 Global Donepezil Sales Volume by Type (2020-2031)
      • 3.1.1.2 Global Donepezil Sales Market Share by Type (2020-2031)
    • 3.1.2 Global Donepezil Revenue by Type (2020-2031)
      • 3.1.2.1 Global Donepezil Revenue by Type (2020-2031)
      • 3.1.2.2 Global Donepezil Revenue Market Share by Type (2020-2031)
    • 3.1.3 Donepezil Average Selling Price (ASP) by Type (2020-2031)
  • 3.2 Breakdown Data by Application
    • 3.2.1 Global Donepezil Sales by Application (2020-2031)
      • 3.2.1.1 Global Donepezil Sales Volume by Application (2020-2031)
      • 3.2.1.2 Global Donepezil Sales Market Share by Application (2020-2031)
    • 3.2.2 Global Donepezil Revenue by Application (2020-2031)
      • 3.2.2.1 Global Donepezil Revenue by Application (2020-2031)
      • 3.2.2.2 Global Donepezil Revenue Market Share by Application (2020-2031)
    • 3.2.3 Donepezil Average Selling Price (ASP) by Application (2020-2031)
  • 3.3 by Type and by Application Crossing Analysis
    • 3.3.1 5mg of Donepezil Revenue Market Share by Application
    • 3.3.2 10mg of Donepezil Revenue Market Share by Application
    • 3.3.3 23mg of Donepezil Revenue Market Share by Application

4 Global Donepezil by Manufacturers

  • 4.1 Global Top Donepezil Manufacturers by Sales (2020-2025)
    • 4.1.1 Global Donepezil Sales by Manufacturer (2020-2025)
    • 4.1.2 Global Donepezil Sales Market Share by Manufacturer (2020-2025)
  • 4.2 Global Top Donepezil Manufacturers by Revenue (2020-2025)
    • 4.2.1 Global Donepezil Revenue by Manufacturer (2020-2025)
    • 4.2.2 Global Donepezil Revenue Share by Manufacturer (2020-2025)
  • 4.3 Global Donepezil Price by Manufacturer (2020-2025)
  • 4.4 Competitive Landscape
    • 4.4.1 Key Donepezil Manufacturers Covered: Ranking by Revenue
    • 4.4.2 Global Donepezil Market Concentration Ratio (CR5 and HHI) & (2020-2025)
    • 4.4.3 Global Donepezil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5 Global Donepezil Manufacturing Base Distribution, Product Type
    • 4.5.1 Donepezil Manufacturers Manufacturing Base Distribution, Headquarters
    • 4.5.2 Date of International Manufacturers Enter into Donepezil Market
    • 4.5.3 Manufacturers Donepezil Product Type and Application
    • 4.5.4 5mg Market Sales of Donepezil by Manufacturer
    • 4.5.5 10mg Market Sales of Donepezil by Manufacturer
    • 4.5.6 23mg Market Sales of Donepezil by Manufacturer
  • 4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

  • 5.1 Eisai
    • 5.1.1 Eisai Company Information
    • 5.1.2 Eisai Description, Business Overview
    • 5.1.3 Eisai Donepezil Products Offered
    • 5.1.4 Eisai Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.1.5 Eisai Donepezil Sales by Product in 2024
    • 5.1.6 Eisai Donepezil Sales by Application in 2024
    • 5.1.7 Eisai Donepezil Sales by Geographic Area in 2024
    • 5.1.8 Eisai Recent Developments
  • 5.2 Pfizer
    • 5.2.1 Pfizer Company Information
    • 5.2.2 Pfizer Description, Business Overview
    • 5.2.3 Pfizer Donepezil Products Offered
    • 5.2.4 Pfizer Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.2.5 Pfizer Donepezil Sales by Product in 2024
    • 5.2.6 Pfizer Donepezil Sales by Application in 2024
    • 5.2.7 Pfizer Donepezil Sales by Geographic Area in 2024
    • 5.2.8 Pfizer Recent Developments
  • 5.3 Teva
    • 5.3.1 Teva Company Information
    • 5.3.2 Teva Description, Business Overview
    • 5.3.3 Teva Donepezil Products Offered
    • 5.3.4 Teva Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.3.5 Teva Donepezil Sales by Product in 2024
    • 5.3.6 Teva Donepezil Sales by Application in 2024
    • 5.3.7 Teva Donepezil Sales by Geographic Area in 2024
    • 5.3.8 Teva Recent Developments
  • 5.4 Sandoz
    • 5.4.1 Sandoz Company Information
    • 5.4.2 Sandoz Description, Business Overview
    • 5.4.3 Sandoz Donepezil Products Offered
    • 5.4.4 Sandoz Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.4.5 Sandoz Donepezil Sales by Product in 2024
    • 5.4.6 Sandoz Donepezil Sales by Application in 2024
    • 5.4.7 Sandoz Donepezil Sales by Geographic Area in 2024
    • 5.4.8 Sandoz Recent Developments
  • 5.5 Apotex
    • 5.5.1 Apotex Company Information
    • 5.5.2 Apotex Description, Business Overview
    • 5.5.3 Apotex Donepezil Products Offered
    • 5.5.4 Apotex Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.5.5 Apotex Donepezil Sales by Product in 2024
    • 5.5.6 Apotex Donepezil Sales by Application in 2024
    • 5.5.7 Apotex Donepezil Sales by Geographic Area in 2024
    • 5.5.8 Apotex Recent Developments
  • 5.6 Dr Reddy's Laboratories
    • 5.6.1 Dr Reddy's Laboratories Company Information
    • 5.6.2 Dr Reddy's Laboratories Description, Business Overview
    • 5.6.3 Dr Reddy's Laboratories Donepezil Products Offered
    • 5.6.4 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.6.5 Dr Reddy's Laboratories Donepezil Sales by Product in 2024
    • 5.6.6 Dr Reddy's Laboratories Donepezil Sales by Application in 2024
    • 5.6.7 Dr Reddy's Laboratories Donepezil Sales by Geographic Area in 2024
    • 5.6.8 Dr Reddy's Laboratories Recent Developments
  • 5.7 Sun Pharmaceutical
    • 5.7.1 Sun Pharmaceutical Company Information
    • 5.7.2 Sun Pharmaceutical Description, Business Overview
    • 5.7.3 Sun Pharmaceutical Donepezil Products Offered
    • 5.7.4 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.7.5 Sun Pharmaceutical Donepezil Sales by Product in 2024
    • 5.7.6 Sun Pharmaceutical Donepezil Sales by Application in 2024
    • 5.7.7 Sun Pharmaceutical Donepezil Sales by Geographic Area in 2024
    • 5.7.8 Sun Pharmaceutical Recent Developments
  • 5.8 Hansoh Pharma
    • 5.8.1 Hansoh Pharma Company Information
    • 5.8.2 Hansoh Pharma Description, Business Overview
    • 5.8.3 Hansoh Pharma Donepezil Products Offered
    • 5.8.4 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.8.5 Hansoh Pharma Donepezil Sales by Product in 2024
    • 5.8.6 Hansoh Pharma Donepezil Sales by Application in 2024
    • 5.8.7 Hansoh Pharma Donepezil Sales by Geographic Area in 2024
    • 5.8.8 Hansoh Pharma Recent Developments
  • 5.9 Cipla
    • 5.9.1 Cipla Company Information
    • 5.9.2 Cipla Description, Business Overview
    • 5.9.3 Cipla Donepezil Products Offered
    • 5.9.4 Cipla Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.9.5 Cipla Donepezil Sales by Product in 2024
    • 5.9.6 Cipla Donepezil Sales by Application in 2024
    • 5.9.7 Cipla Donepezil Sales by Geographic Area in 2024
    • 5.9.8 Cipla Recent Developments
  • 5.10 ARK PHA.LTD
    • 5.10.1 ARK PHA.LTD Company Information
    • 5.10.2 ARK PHA.LTD Description, Business Overview
    • 5.10.3 ARK PHA.LTD Donepezil Products Offered
    • 5.10.4 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.10.5 ARK PHA.LTD Donepezil Sales by Product in 2024
    • 5.10.6 ARK PHA.LTD Donepezil Sales by Application in 2024
    • 5.10.7 ARK PHA.LTD Donepezil Sales by Geographic Area in 2024
    • 5.10.8 ARK PHA.LTD Recent Developments
  • 5.11 Jishengtang Pharma
    • 5.11.1 Jishengtang Pharma Company Information
    • 5.11.2 Jishengtang Pharma Description, Business Overview
    • 5.11.3 Jishengtang Pharma Donepezil Products Offered
    • 5.11.4 Jishengtang Pharma Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.11.5 Jishengtang Pharma Donepezil Sales by Product in 2024
    • 5.11.6 Jishengtang Pharma Donepezil Sales by Application in 2024
    • 5.11.7 Jishengtang Pharma Donepezil Sales by Geographic Area in 2024
    • 5.11.8 Jishengtang Pharma Recent Developments
  • 5.12 Luoxin
    • 5.12.1 Luoxin Company Information
    • 5.12.2 Luoxin Description, Business Overview
    • 5.12.3 Luoxin Donepezil Products Offered
    • 5.12.4 Luoxin Donepezil Sales, Revenue and Gross Margin (2020-2025)
    • 5.12.5 Luoxin Donepezil Sales by Product in 2024
    • 5.12.6 Luoxin Donepezil Sales by Application in 2024
    • 5.12.7 Luoxin Donepezil Sales by Geographic Area in 2024
    • 5.12.8 Luoxin Recent Developments

6 North America

  • 6.1 North America Donepezil Market Size YoY Growth 2020-2031
  • 6.2 North America Donepezil Market Facts & Figures by Country
    • 6.2.1 North America Donepezil Sales by Country (2020-2031)
    • 6.2.2 North America Donepezil Revenue by Country (2020-2031)
  • 6.3 North America Donepezil Sales by Type (2020-2025)
  • 6.4 North America Donepezil Sales by Application (2020-2025)

7 Asia-Pacific

  • 7.1 Asia-Pacific Donepezil Market Size YoY Growth 2020-2031
  • 7.2 Asia-Pacific Donepezil Market Facts & Figures by Region
    • 7.2.1 Asia-Pacific Donepezil Sales by Region (2020-2031)
    • 7.2.2 Asia-Pacific Donepezil Revenue by Region (2020-2031)
  • 7.3 Asia-Pacific Donepezil Sales by Type (2020-2025)
  • 7.4 Asia-Pacific Donepezil Sales by Application (2020-2025)

8 Europe

  • 8.1 Europe Donepezil Market Size YoY Growth 2020-2031
  • 8.2 Europe Donepezil Market Facts & Figures by Country
    • 8.2.1 Europe Donepezil Sales by Country (2020-2031)
    • 8.2.2 Europe Donepezil Revenue by Country (2020-2031)
  • 8.3 Europe Donepezil Sales by Type (2020-2025)
  • 8.4 Europe Donepezil Sales by Application (2020-2025)

9 Latin America

  • 9.1 Latin America Donepezil Market Size YoY Growth 2020-2031
  • 9.2 Latin America Donepezil Market Facts & Figures by Country
    • 9.2.1 Latin America Donepezil Sales by Country (2020-2031)
    • 9.2.2 Latin America Donepezil Revenue by Country (2020-2031)
  • 9.3 Latin America Donepezil Sales by Type (2020-2025)
  • 9.4 Latin America Donepezil Sales by Application (2020-2025)

10 Middle East and Africa

  • 10.1 Latin America Donepezil Market Size YoY Growth 2020-2031
  • 10.2 Middle East and Africa Donepezil Market Facts & Figures by Country
    • 10.2.1 Middle East and Africa Donepezil Sales by Country (2020-2031)
    • 10.2.2 Middle East and Africa Donepezil Revenue by Country (2020-2031)
  • 10.3 Middle East and Africa Donepezil Sales by Type (2020-2025)
  • 10.4 Middle East and Africa Donepezil Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

  • 11.1 Donepezil Supply Chain Analysis
  • 11.2 Donepezil Key Raw Materials and Upstream Suppliers
  • 11.3 Donepezil Clients Analysis
  • 11.4 Donepezil Sales Channel and Sales Model Analysis
    • 11.4.1 Donepezil Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 11.4.2 Donepezil Distribution Channel Analysis: Online Sales VS Offline Sales
    • 11.4.3 Donepezil Distributors

12 Donepezil Market Dynamics

  • 12.1 Donepezil Industry Trends
  • 12.2 Donepezil Market Drivers
  • 12.3 Donepezil Market Challenges
  • 12.4 Donepezil Market Restraints

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
      • 14.1.1.1 Research Programs/Design
      • 14.1.1.2 Market Size Estimation
      • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
      • 14.1.2.1 Secondary Sources
      • 14.1.2.2 Primary Sources
  • 14.2 Author Details
  • 14.3 Disclaimer